UPDATED: Clinical Trial Results Announced in Study of Peginterferon Beta-1a – Company Submits Applic
UPDATED: Clinical Trial Results Announced in Study of Peginterferon Beta-1a – Company Submits Applic/About-the-Society/News/UPDATED-Clinical-Trial-Results-Announced-in-Study … read morePosted At: National MS Society
A decline in cognitive function should lead to a change in disease-modifying therapy – CommentaryMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Results Announced from a Phase III Trial of Laquinimod in Relapsing MS – Trial in Primary Progressi/About-the-Society/News/Results-Announced-from-a-Phase-III-Trial-of-Laquin … read morePosted At: National MS Society
Cerebral rituximab uptake in multiple sclerosis: A 89Zr-immunoPET pilot studyMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Imaging of meningeal inflammation should become part of the routine MRI protocol – NoMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Join Our Mailing List
- Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis
- What are the early signs of MS?
- Silent lesions on MRI imaging – Shifting goal posts for treatment decisions in multiple sclerosis
- Treatment decisions in MS: Shifting the goal posts or changing how we see them?
- How to give an intramuscular injection
- Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry
- e-Health and multiple sclerosis: An update
- Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System
- Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis
- MS: Is a ‘rogue’ brain and lymph node interaction to blame?